Literature DB >> 4023180

Thermal sensitivity of endothelial cells.

L F Fajardo, A B Schreiber, N I Kelly, G M Hahn.   

Abstract

Experimental work indicates that one of the mechanisms of tumor control by hyperthermia may be damage to blood vessels, resulting in decreased blood flow to the neoplasms. Among the various elements of the microvasculature, endothelial cells are the most important possible targets of thermal injury. Furthermore, neoplasms have a significantly higher proportion of proliferating endothelial cells than do normal tissues. Thus it is necessary to establish the thermal sensitivity of endothelial cells and to explore possible differences in response between resting and proliferating endothelium. We studied the in vitro thermal sensitivity of murine and human capillary endothelial cells compared to human fibroblasts by following cell survival and growth recovery. Nonstimulated endothelial cells are more sensitive than fibroblasts. Their sensitivity is dose dependent within the range of 42 to 45 degrees C/30 min. Stimulation to proliferate by endothelial cell growth factor (ECGF) renders these cells even more sensitive. Morphologic studies confirm these thermal effects in endothelial cells and fibroblasts. These findings support a direct effect of hyperthermia on endothelial cells, which appears to be more severe in proliferating cells. This may explain the reduced blood flow in heated tumors and may indicate a valuable therapeutic gain for hyperthermia.

Entities:  

Mesh:

Year:  1985        PMID: 4023180

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  12 in total

1.  A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance.

Authors:  Ardith W El-Kareh; Timothy W Secomb
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

2.  Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic.

Authors:  A M Duijvestijn; A B Schreiber; E C Butcher
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Dynamic topographical control of mesenchymal stem cells by culture on responsive poly(ε-caprolactone) surfaces.

Authors:  Duy M Le; Karina Kulangara; Andrew F Adler; Kam W Leong; Valerie Sheares Ashby
Journal:  Adv Mater       Date:  2011-05-30       Impact factor: 30.849

4.  Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy.

Authors:  Adam J Gormley; Nate Larson; Shraddha Sadekar; Ryan Robinson; Abhijit Ray; Hamidreza Ghandehari
Journal:  Nano Today       Date:  2012-05-24       Impact factor: 20.722

5.  Gold nanorod mediated plasmonic photothermal therapy: a tool to enhance macromolecular delivery.

Authors:  Adam J Gormley; Khaled Greish; Abhijit Ray; Ryan Robinson; Joshua A Gustafson; Hamidreza Ghandehari
Journal:  Int J Pharm       Date:  2011-06-12       Impact factor: 5.875

Review 6.  Vascular attack as a therapeutic strategy for cancer.

Authors:  J Denekamp
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

7.  Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers.

Authors:  Adam J Gormley; Nate Larson; Afsheen Banisadr; Ryan Robinson; Nick Frazier; Abhijit Ray; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2012-12-20       Impact factor: 9.776

8.  Stromal sensitivity to radiation and hyperthermia.

Authors:  S A Hill; K A Smith; J Denekamp
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

Review 9.  Tumour vasculature--a potential therapeutic target.

Authors:  C T Baillie; M C Winslet; N J Bradley
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

10.  The impact of surgery and mild hyperthermia on tumor response and angioneogenesis of malignant melanoma in a rat perfusion model.

Authors:  Joerg Pelz; Marco Mollwitz; Christian Stremmel; Jonas Goehl; Arno Dimmler; Werner Hohenberger; Thomas Meyer
Journal:  BMC Cancer       Date:  2004-08-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.